Skip to main content
Erschienen in: Journal of Clinical Immunology 7/2021

02.06.2021 | Letter to Editor

A Case of VEXAS Syndrome Complicated by Hemophagocytic Lymphohistiocytosis

verfasst von: Alice Grey, Pak Leng Cheong, Frederick J. Lee, Edward Abadir, James Favaloro, Shihong Yang, Stephen Adelstein

Erschienen in: Journal of Clinical Immunology | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Excerpt

To the Editors, …
Literatur
1.
Zurück zum Zitat Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:399. Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:399.
2.
Zurück zum Zitat Beck DB, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–38.CrossRef Beck DB, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–38.CrossRef
5.
Zurück zum Zitat Egues Dubuc CA, et al. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. Literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317–A317.CrossRef Egues Dubuc CA, et al. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. Literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317–A317.CrossRef
7.
Zurück zum Zitat Henter J-I, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRef Henter J-I, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRef
9.
Zurück zum Zitat Magnol M, Couvaras L, Degboé Y, Delabesse E, Bulai-Livideanu C, Ruyssen-Witrand A, et al. VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy. Rheumatology. 2021. https://doi.org/10.1093/rheumatology/keab211. Magnol M, Couvaras L, Degboé Y, Delabesse E, Bulai-Livideanu C, Ruyssen-Witrand A, et al. VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy. Rheumatology. 2021. https://​doi.​org/​10.​1093/​rheumatology/​keab211.
12.
Zurück zum Zitat Rouphael NG, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814–22.CrossRef Rouphael NG, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814–22.CrossRef
Metadaten
Titel
A Case of VEXAS Syndrome Complicated by Hemophagocytic Lymphohistiocytosis
verfasst von
Alice Grey
Pak Leng Cheong
Frederick J. Lee
Edward Abadir
James Favaloro
Shihong Yang
Stephen Adelstein
Publikationsdatum
02.06.2021
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 7/2021
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01070-y

Weitere Artikel der Ausgabe 7/2021

Journal of Clinical Immunology 7/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.